ALS Clinical Trials in San Antonio

Showing 1-20 of 43 trials

Clinical Procedures to Support Research in ALS

NCT03489278

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Amyotrophic Lateral SclerosisALS-Frontotemporal DementiaPrimary Lateral Sclerosis+1 more

University of Miami1,200 participantsStarted Feb 2018

Irvine, California, United States • Palo Alto, California, United States • San Francisco, California, United States +8 more locations

COMPLETEDPhase 1< 1 mile

A First in Human Study of ORT247 in Healthy Volunteers

NCT06769620

This is a single center, double-blinded, randomized, placebo controlled single ascending dose clinical study, with the primary purpose of evaluating the safety, tolerability, pharmacokinetics (PK), and immunohistochemistry of escalating intravenous doses of ORT247 in healthy volunteers.

Amyotrophic Lateral Sclerosis (ALS)

Orthogonal Neuroscience Inc.44 participantsStarted Jun 2022

San Antonio, Texas, United States

TERMINATEDPhase 3< 1 mile

Phase 3 Extension Study of Dexpramipexole in ALS

NCT01622088

The purpose of the study is to collect long-term safety data from subjects with Amyotrophic Lateral Sclerosis (ALS) exposed to dexpramipexole.

Amyotrophic Lateral Sclerosis

Knopp Biosciences616 participantsStarted Jun 2012

Phoenix, Arizona, United States • Fresno, California, United States • Orange, California, United States +77 more locations

Clinical Procedures to Support Research in ALS

A First in Human Study of ORT247 in Healthy Volunteers

Phase 3 Extension Study of Dexpramipexole in ALS

ALS Trials in Other Cities

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

The Myelin Disorders Biorepository Project

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

PREVENT ALL ALS Study

ASSESS ALL ALS Study

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

Arimoclomol in Amyotropic Lateral Sclerosis

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Long-Term Evaluation of BIIB067 (Tofersen)

Intermuscular Coherence as a Biomarker for ALS

Norms and Validation for IntelliSpace Cognition Spanish Version

Other Conditions in San Antonio